Stay updated with breaking news from Llostem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotechnology company Creative Medical Technology Holdings, Inc. (CELZ) announced Tuesday that it has received Institutional Review Board (IRB) approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine procedure using AlloStem (CELZ-201-DDT) cell therapy. ....
Creative Medical Technology Holdings got FDA clearance for its Phase 1/2 clinical trial for its StemSpine procedure using AlloStem, according to a Sept. 19 news release. ....
Creative Medical Technology Holdings StemSpine procedure was found to be effective in treating chronic lower back pain, according to a pilot study. ....